Stocks in Focus on July 28: IndusInd Bank, Torrent Pharma, InterGlobe, Rollex Rings IPO to Glenmark Life IPO; here are the 5 Newsmakers of the Day

National stock markets ended with losses of around half a percent after a volatile session on Tuesday, July 27, 2021. The S&P BSE Sensex fell 273.51 points or 0.52 percent to close at 52,578.76. The Nifty 50 Index lost 78 points or 0.49 percent to 15,746.45. But certain stocks made the news after the market closed. These stocks may have an impact on the indices when they reopen on Wednesday, July 28, 2021. List of 5 stocks of this type:

IndusInd Bank + Karnataka Bank

IndusInd Bank: The private lender has reported a 99% quarter-on-quarter increase in consolidated earnings to Rs 1,016 million for the quarter ended June 30, 2021. It had posted a gain of Rs 510 million in the corresponding quarter of the previous financial year. Net interest income (NII) grew 7.7% to Rs 3,564 crore in the reported quarter versus Rs 3,309 crore posted last year. Provisions in the quarter fell 18% to Rs 1,844 crore from Rs 2,259 crore posted last year. The gross non-performing asset ratio rose to 2.88% from 2.67% in the previous quarter. Similarly, the net delinquency rate increased to 0.84% โ€‹โ€‹from 0.69% reported in the previous quarter. Chief Executive Officer and Chief Executive Officer Sumant Kathpalia said the bank has set an ambitious 16-18% loan growth target for this fiscal year and expects a recovery in the bank's core areas. He said harvesting efficiency dropped in May but recovered quickly in June and July. The lender has strengthened its balance sheet by increasing the provision coverage ratio (PCR) to 72% in June 2021. Advances grew 6% year-on-year.

Watch Zee Business Live TV broadcast below:

Bank of Karnataka: The private sector Karnataka Bank has reported a 45.9% year-on-year decrease in earnings of Rs 106 million for the quarter ended June 30, 2021, compared to Rs 196 million in the corresponding quarter of the year. previous financial year. Net interest income (NII) grew 7.5% year-on-year to Rs 575 million compared to Rs 535 million recorded last year. Provisions in the quarter fell 27.7% year-on-year to Rs 368 million from Rs 509 million posted last year. Sequentially, provisions grew 7.6% from 342 million rupees recorded in the previous quarter ending March 31, 2021. The gross non-performing assets ratio fell to 4.82% in the first quarter of fiscal 22 from 4.91% reported in the previous quarter. Net delinquencies fell to 3% in the reported quarter from 3.18% in the previous quarter.

Torrent Pharma + Granules India + Aarti Drugs

Torrent Pharma: Pharmaceutical company Torrent Pharmaceuticals has reported a 3% year-on-year increase in profit of Rs 330 crore for the quarter ended June 30, 2021. It had posted a profit of Rs 321 crore in the corresponding quarter of the previous financial year. . Operating income grew 4% year-on-year to Rs 2,134 crore compared to Rs 2,056 crore recorded last year. EBITDA grew 2.4% year-on-year to Rs 677 crore compared to Rs 661 crore. The margin stood at 31.7% in Q1FY22 compared to 32% registered in Q1FY21. The company said that sales in India grew 18%, while sales in the United States fell 29%.

Granules: Pharmaceutical company Granules India has reported an 8% year-on-year increase in consolidated profit of Rs 120 million for the quarter ended June 30, 2021. It had posted a profit of Rs 111 million in the corresponding quarter of the financial year. previous. Income from operations grew 16% year-on-year to Rs 850 million compared to Rs 736 million recorded last year. EBITDA grew 10% to Rs 201 crore compared to Rs 183 crore recorded last year. The margin fell to 24% in Q1FY22 from 25% posted in Q1FY21. The company said in a statement that the segment of pharmaceutical formulation intermediates (PFI) grew 25%, while active pharmaceutical ingredients (API) grew 5% and finished doses (DF) 18%.

Aarti drugs: The pharmaceutical company has reported a 43% year-on-year decrease in consolidated profit to Rs 48.8 million for the quarter ended June 30, 2021. It had posted a Rs 85.45 million profit in the corresponding quarter of the year. previous financial year. Sequentially, profit fell 6% from Rs 51.6 crore posted in the previous quarter ending March 31, 2021. Consolidated revenue from operations grew 6.5% year-on-year to Rs 580 crore in the reported quarter versus Rs 545 crore issued last year. Sequentially, revenue grew 15% from Rs 502 crore in the previous quarter. EBITDA fell 40% year-on-year to Rs 79.7 crore versus Rs 134 crore posted last year. Sequentially, EBITDA fell 1.2% from Rs 81 crore posted in the previous quarter. The company has reported a margin of 13.7% in Q1FY22 compared to 24.5% registered in Q1FY21 and 16% registered in Q4FY21. Details by segment:

- API: 3.9% year-on-year; 13.8% quarter-on-quarter

- Formulation: 6.7% year-on-year, 40.1% quarter-on-quarter

- Specialty Chemicals: 38.9% YoY, (1.7)% YoY

InterGlobe + Dalia Bharat + IIFL Finance

InterGlobe Aviation: Interglobe Aviation, the company that flies with the airline IndiGo, has reported a loss of Rs 3,174 crore for the quarter ended June 30, 2021. It had recorded a loss of Rs 1,157.5 crore in the previous quarter ended March 31 2021. Income from operations decreased 51% qoq to Rs 3,006 crore compared to Rs 6,222.9 crore. EBITDAR loss stood at Rs 1,360 crore in the reported quarter versus EBITDAR gain of Rs 651.6 crore posted in the prior quarter.

Dalmia India: The company has reported a 19% year-on-year increase in consolidated earnings to Rs 227 million for the quarter ended June 30, 2021. It had posted a Rs 190 million profit in the corresponding quarter of the previous financial year. Sales on a consolidated basis grew 36% to Rs 2,589 crore compared to Rs 1,901 crore posted last year. EBITDA grew 30% to Rs 2,575 crore compared to Rs 1,974 crore posted last year. The margin fell to 99% in Q1FY22 from 103.8% in Q1FY21.

IIFL Finance: The financial services company has reported a 550% year-on-year increase in consolidated profit of Rs 104 million for the quarter ended June 30, 2021. It had posted a profit of Rs 16 million in the corresponding quarter of the financial year. previous. Sales on a consolidated basis grew 11% to Rs 816 crore in the reported quarter compared to Rs 732 crore posted last year. EBITDA grew 31.5% year-on-year to Rs 563 crore compared to Rs 428 crore posted last year. Margins improved to 68.9% in Q1FY22 compared to 58% in Q1FY21.

Rollex + Glenmark Life + HUDCO Rings

Rollex Rings: The Initial Public Offering (IPO) of Rollex Rings will hit the market today and will close on July 30, 2021. The company has set the price band for the issue in the range of Rs 880-900. The company seeks to raise 731 million rupees through public issuance. In the block there is a new issue of shares totaling up to Rs 56 crore and an offer to sell of up to 7,500,000 shares worth Rs 675 crore. Investors can bid for a minimum of 16 equity shares and in multiples of 16 thereafter. Additionally, Rolex Rings, one of the top five forging companies in India, has raised Rs 219 crore from 26 anchor investors on July 27, ahead of the IPO opening. The company has allocated Rs 24.4 lakhs of shares to anchor investors at Rs 900 per share. Anchor investors include HDFC Fund 10%, ICICI Prudential Fund 10%, SBI Fund 10%, Axis Mutual Fund 9.13% and Aditya Birla Sun Life 9.1%, among others.

Glenmark Life Sciences IPO: The initial public offering (IPO) of Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals, was subscribed 2.78 times on the first day of subscription. The NII portion of the public offering was subscribed 0.86 times and the retail portion was subscribed 5.17 times, while the QIB has not yet bid on the issue. The issuance will close on July 29, 2021. The company seeks to raise up to Rs 1,513.6 million from primary market investors. The offering price band has been set at Rs 695-720 per share and investors can bid for a minimum of 20 equity shares, in a single lot, and in multiples of 20 equity shares thereafter. The initial public offering (IPO) will have a new issue of shares worth up to Rs 1,060 crore and the sale of up to 63 lakh of shares by Glenmark Pharma.

HUDCO: The non-retail portion of the Housing and Urban Development Corporation (HUDCO) Limited sale offering was subscribed 1.96 times on the first day. The OFS will open today for retail investors. The government is trying to sell around 11.01 million shares (5.5% of the capital stock) in the Housing and Urban Development Corporation (HUDCO) Limited through an Offer to Sell (OFS) at a minimum price of 45 rupees per share. It has maintained an oversubscription of shares of 2.5% or more than 5 million shares. So the government is looking to ditch an 8% stake (over 16 million equity shares) in HUDCO, which could help it get Rs 720 crore for its divestment kitty.

Marriage + Punjab Alkalis

Matrimony.com: SBI Mutual Fund sold a 1.85% stake (4.25 lakh shares) in the company through an open market transaction, reducing the equity stake to 3.22% from 5.08% previous.
Punjab Alkalies: Plutus Wealth Management LLP bought shares from 2.5 lakh to 114 per share.

Leave a Comment

Comments

No comments yet. Why donโ€™t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *